NEI Research News

Neuroscientists at Johns Hopkins Medicine have shown that intrinsically-photosensitive retinal ganglion cells use two different pathways at the same time to transmit electrical “vision” signals to the brain.

Researchers combined retinal imaging, genetics and big data to estimate how likely a person is to develop eye and systemic diseases in the future.

A new analysis focusing specifically on people of African ancestry identified three gene variants that may be contributing to this population’s susceptibility to developing and being blinded by glaucoma.

University of Wisconsin-Madison study to support development of more sensitive ways to assess canine vision discovers what dogs most like to watch.

NEI researchers improved a crucial step in the production of retinal pigment epithelium (RPE), a tissue they grow in the lab from patient blood cells and are testing in a clinical trial as treatment for AMD.

A study of children and youth with diabetes concludes that diabetic eye exams using artificial intelligence (AI) increase completion rates of screenings to detect diabetic eye disease.

The National Institutes of Health sponsored its first-ever workshop on cerebral visual impairment (CVI), an umbrella term for subnormal vision resulting from brain injury during development.

By adapting virus-like particles to carry the machinery for a type of gene editing called prime editing, scientists have corrected disease-causing mutations in animals and increased editing efficiency.

Researchers at Indiana University School of Medicine are using a novel approach to hopefully develop a new therapy for glaucoma, a complex disease that eventually leads to blindness.

A team of scientists have received funding to explore new approaches to disentangle intricate nerve networks in the cornea and discover which nerve makes people blink, which creates tears and which nerve tells us our eye is in pain.